Holen Sie sich die Stockscreener-App
32.09
1.23%
0.43
Schlusskurs vom Vortag:
$31.66
Offen:
$31.27
24-Stunden-Volumen:
104.64K
Relative Volume:
1.68
Marktkapitalisierung:
$380.10M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+33.10%
1M Leistung:
+307.24%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$30.55
$32.97
1-Wochen-Bereich:
$22.35
$37.08
52-Wochen-Spanne:
$5.60
$37.08
Anbio Biotechnology Stock (NNNN) Company Profile
Vergleichen Sie NNNN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
32.05 | 380.10M | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
534.47 | 189.82B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
176.18 | 49.98B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.69 | 44.00B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
256.20 | 37.05B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
220.37 | 16.36B | 2.90B | 467.20M | 306.90M | 6.37 |
Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten
Anbio Biotechnology: Risky Valuation Concerns As COVID-Related Sales Decline (NNNN) - Seeking Alpha
Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions - The Manila Times
Anbio Biotechnology to Showcase Innovative Diagnostic Solutions at Key International Exhibitions in May 2025 - Nasdaq
Anbio Expands Global Diagnostics Reach: 90+ Tests, 100+ Countries, and 3 Major Exhibition Debuts - Stock Titan
Highest quarter in years as med-tech raises $8B in Q1 financings - BioWorld MedTech
Financing Quarterly Statistics, Q1 2025 - insights.citeline.com
US Market's Undiscovered Gems and 2 Other Promising Small Caps - Yahoo Finance
Unveiling US Market's Undiscovered Gems April 2025 - simplywall.st
Uncovering Hidden Opportunities In US With These 3 Undiscovered Gems - Yahoo Finance
US Market's Undiscovered Gems Featuring ZJK Industrial And 2 More Small Caps - simplywall.st
US Undiscovered Gems to Explore in April 2025 - Yahoo Finance
Discovering US Market's Undiscovered Gems April 2025 - simplywall.st
US Undiscovered Gems To Explore In April 2025 - Yahoo Finance
Undiscovered Gems in the US Market for April 2025 - simplywall.st
US Market's Undiscovered Gems for April 2025 - simplywall.st
Exploring US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 US Undiscovered Gems with Strong Potential - simplywall.st
US Undiscovered Gems To Watch In April 2025 - simplywall.st
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday - Benzinga
Discovering US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 Undiscovered Gems In The US Market - simplywall.st
US Market Undiscovered Gems To Explore In March 2025 - simplywall.st
US Market's Top 3 Undiscovered Gems With Strong Potential - simplywall.st
Discovering US Undiscovered Gems in March 2025 - Simply Wall St
US Market's Top 3 Undiscovered Gems with Strong Fundamentals - Simply Wall St
Uncovering 3 Undiscovered Gems In The US Market - Simply Wall St
US Market's Undiscovered Gems for March 2025 - Simply Wall St
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
Amaran Biotech Signs MOU with Nippon Fine Chemical - GlobeNewswire Inc.
Is the IPO Market Shutting Down? - Cabot Wealth Network
Kestra Medical ups IPO target to $150M - BioWorld Online
Unlocking Anbio's IPO: A Pivotal Shift in Global Diagnostics! - Mi Valle
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha
IPO NewsUS IPO Weekly Recap: IPO calendar slows down with small listings - Renaissance Capital
Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps - Yahoo Finance
Fresh Biotech Player Enters Nasdaq: Will Anbio's $8M IPO Fuel Its Global Expansion? - Stock Titan
Anbio Biotechnology's IPO opens up 5% By Investing.com - Investing.com South Africa
Anbio Biotechnology’s IPO opens up 5% By Investing.com - Investing.com Australia
Anbio Biotechnology Share Price | NASDAQ: NNNN Stock - Investing.com UK
Anbio Biotechnology's IPO opens up 5% - Investing.com
Anbio Biotechnology’s IPO Set to Revolutionize Global Diagnostics - Mi Valle
NNNNANBIO BIOTECHNOLOGY Latest Stock News & Market Updates - Stock Titan
Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East - PR Newswire
Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency - PR Newswire
Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha
NNNN IPO NewsGermany-based diagnostics products developer Anbio Biotechnology files for a $9 million US IPO - Renaissance Capital
Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024 - PR Newswire
Enzyme Immunoassay Market Size to Hit USD 26.55 Billion by 2033 - BioSpace
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions - PR Newswire
Anbio advances POC testing with new FIA analyzer - SelectScience
Anbio Biotechnology to Showcase ABO & Rhd Blood Grouping Kit at Medlab Middle East 2024 - PR Newswire
Finanzdaten der Anbio Biotechnology-Aktie (NNNN)
Es liegen keine Finanzdaten für Anbio Biotechnology (NNNN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.24%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):